Business Description
TransMedics Group Inc
NAICS : 334510
SIC : 3845
ISIN : US89377M1099
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.77 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 3.76 | |||||
| Debt-to-EBITDA | -66.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.07 | |||||
| Beneish M-Score | 2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 92.7 | |||||
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 12.4 | |||||
| 3-Year FCF Growth Rate | -68.1 | |||||
| 3-Year Book Growth Rate | 3.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 38.38 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.95 | |||||
| 9-Day RSI | 52.87 | |||||
| 14-Day RSI | 54.4 | |||||
| 6-1 Month Momentum % | 72.81 | |||||
| 12-1 Month Momentum % | 8.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | |||||
| Quick Ratio | 8.49 | |||||
| Cash Ratio | 7.19 | |||||
| Days Inventory | 132.36 | |||||
| Days Sales Outstanding | 71.9 | |||||
| Days Payable | 33.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -12.11 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.77 | |||||
| Operating Margin % | -11.89 | |||||
| Net Margin % | -10.36 | |||||
| FCF Margin % | -80.02 | |||||
| ROE % | -15.86 | |||||
| ROA % | -4.72 | |||||
| ROIC % | -19.97 | |||||
| ROC (Joel Greenblatt) % | -12.45 | |||||
| ROCE % | -3.23 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 238.08 | |||||
| PS Ratio | 11.75 | |||||
| PB Ratio | 20.77 | |||||
| Price-to-Tangible-Book | 23.18 | |||||
| EV-to-EBIT | -188.1 | |||||
| EV-to-EBITDA | -387.78 | |||||
| EV-to-Revenue | 12.36 | |||||
| EV-to-Forward-Revenue | 8.1 | |||||
| EV-to-FCF | -15.55 | |||||
| Earnings Yield (Greenblatt) % | -0.53 | |||||
| FCF Yield % | -6.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TransMedics Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 223.918 | ||
| EPS (TTM) (€) | -0.724 | ||
| Beta | 0 | ||
| Volatility % | 111.04 | ||
| 14-Day RSI | 54.4 | ||
| 14-Day ATR (€) | 3.077919 | ||
| 20-Day SMA (€) | 75.891 | ||
| 12-1 Month Momentum % | 8.39 | ||
| 52-Week Range (€) | 35.1 - 90.5 | ||
| Shares Outstanding (Mil) | 32.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TransMedics Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TransMedics Group Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
TransMedics Group Inc Frequently Asked Questions
What is TransMedics Group Inc(STU:TMDX)'s stock price today?
The current price of STU:TMDX is €81.60. The 52 week high of STU:TMDX is €90.50 and 52 week low is €35.10.
When is next earnings date of TransMedics Group Inc(STU:TMDX)?
The next earnings date of TransMedics Group Inc(STU:TMDX) is 2024-04-30.
Does TransMedics Group Inc(STU:TMDX) pay dividends? If so, how much?
TransMedics Group Inc(STU:TMDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers